Glycoprotein IIb/IIIa inhibitors in acute coronary syndromes

被引：0

作者：

Roe, MT ^{[1
]}

Sapp, SK ^{[1
]}

Lincoff, AM ^{[1
]}

机构：

[1] Cleveland Clin Fdn, Dept Cardiol, Cleveland, OH 44195 USA

来源：

CLEVELAND CLINIC JOURNAL OF MEDICINE | 2000年 / 67卷 / 02期

关键词：

D O I：

暂无

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

Glycoprotein (GP) IIb/IIIa inhibitors are potent antiplatelet agents and represent an exciting breakthrough in the treatment of acute coronary syndromes. However, their safety and cost-effectiveness require further investigation, and more information on risk stratification is needed to clarify which patients benefit the most from empiric use of these agents.

引用

页码：131 / 140

页数：12

共 50 条

[11] Glycoprotein IIb/IIIa antagonists in acute coronary syndromes
Maree, A
Fitzgerald, D
HAEMATOLOGICA, 2001, 86 (11) : 45 - 48
[12] Use of glycoprotein IIb/IIIa inhibitors in patients with acute coronary syndromes undergoing coronary revascularization
Popma, JJ
HAEMOSTASIS, 1999, 29 : 69 - 71
[13] Glycoprotein IIb/IIIa inhibitors in acute coronary syndromes: Pathophysiologic foundation and clinical findings
Kleiman, NS
Lincoff, AM
Ohman, EM
Harrington, RA
AMERICAN HEART JOURNAL, 1998, 136 (04) : S32 - S42
[14] The evolving role of platelet glycoprotein IIb IIIa inhibitors in the management of acute coronary syndromes
Stringer, KA
ANNALS OF PHARMACOTHERAPY, 1999, 33 (06) : 712 - 722
[15] Overview of clinical trials of glycoprotein IIb-IIIa inhibitors in acute coronary syndromes
Harrington, RA
AMERICAN HEART JOURNAL, 1999, 138 (04) : S276 - S286
[16] Glycoprotein IIb/IIIa receptor blockers in acute coronary syndromes
Störk, T
Fröhlich, E
Möckel, M
LANCET, 2001, 358 (9297): : 1996 - 1997
[17] Platelet glycoprotein IIb/IIIa inhibition in acute coronary syndromes
Mak K.H.
Moliterno D.J.
Current Cardiology Reports, 1999, 1 (3) : 199 - 205
[18] Controversies surrounding platelet glycoprotein IIb/IIIa inhibitors in percutaneous coronary intervention and acute coronary syndromes
Harrington, RA
SEMINARS IN THROMBOSIS AND HEMOSTASIS, 2004, 30 (06): : 639 - 647
[19] Evaluating the benefits of glycoprotein, IIb/IIIa inhibitors in heart failure at baseline in acute coronary syndromes
Srichai, MB
Jaber, WA
Prior, DL
Marso, SP
Houghtaling, PL
Menon, V
Simoons, ML
Harrington, RA
Hochman, JS
AMERICAN HEART JOURNAL, 2004, 147 (01) : 84 - 90
[20] A prospective analysis of complications related to the use of glycoprotein IIb/IIIa inhibitors in acute coronary syndromes
RM Rocha
CT Mesquita
MCFS Kanto
FS Lugão
AL Cascardo
PS Lira
FOD Rangel
R Esporcatte
Critical Care, 5 (Suppl 6):

← 1 2 3 4 5 →